2021年最新SCI期刊影响因子查询系统
Neurodegenerative Diseases 期刊详细信息
基本信息
期刊名称 | Neurodegenerative Diseases Neurodegenerative Diseases |
---|---|
期刊ISSN | 1660-2854 |
期刊官方网站 | http://www.karger.com/Journal/Home/229093 |
是否OA | 否 |
出版商 | S. Karger AG |
出版周期 | Bimonthly |
始发年份 | 2004 |
年文章数 | 28 |
最新影响因子 | 3.417(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | CLINICAL NEUROLOGY 临床神经病学3区 | 否 | 否 |
NEUROSCIENCES 神经科学4区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 2.50 | 1.075 | 0.664 |
Neuroscience Neurology |
62 / 148 | 57% |
|||
Medicine Clinical Neurology |
109 / 336 | 67% |
补充信息
自引率 | 1.20% |
---|---|
H-index | 47 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1660-2854%5BISSN%5D |
投稿指南
期刊投稿网址 | http://oper1.karger.com/journals/default.asp?ProduktNr=229093 |
---|---|
收稿范围 | Neurodegenerative Diseases is a bimonthly, multidisciplinary journal for the publication and discussion of advances in research on all aspects of neurodegenerative diseases. The journal focuses on Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and Huntington disease, but will also welcome articles on related neurological and psychiatric disorders. A particular thematic focus is set on the interplay between vascular pathology, neuroinflammatory change, and the progression of neurodegenerative disease. In addition to clinical and basic science studies, brief methodological papers are welcome. This includes the emerging fields of statistical genetics, clinical and preclinical neuroimaging, novel algorithms of biomedical image computing, and basic science approaches to elucidate mechanisms of neurodegenerative disease. Neurodegenerative Diseases accepts high-quality papers in the form of brief reports, original research, or review articles from a broad spectrum of scientific research areas ranging from neuroscience and genetics to clinical and preclinical neuroimaging and biomarker studies, molecular and cell biology as well as pharmacology. All articles will undergo rigorous scientific as well as statistical/bioinformatic review to ensure excellence. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |